A whole-population cancer interception programme: risk-stratify every adult, detect and intercept early
Instead of separate screening programmes for a few cancers, assess every adult's overall cancer risk and offer blood tests, imaging and preventive treatment tuned to that risk, all inside one system that learns.
Screening today covers a handful of cancers with organ-specific programmes and reaches a fraction of eligible people. Multi-cancer early detection blood tests (NHS-Galleri, PATHFINDER 2) and polygenic, exposure and imaging-based risk models make a unified approach conceivable: every adult over 40 receives a risk profile, a personalised detection schedule, and where indicated interception (chemoprevention, vaccines, risk-reducing procedures), with all results feeding a national learning system that recalibrates the models. Overdiagnosis is controlled through molecular indolence classifiers and surveillance-first protocols.
- Most lethal cancers are found late · Screening exists for only a few cancers. Pancreatic, ovarian, liver, oesophageal and most lung cancers are found when cure is unlikely.
- Prevention we already have is not deployed · Around four in ten cancers are preventable with tools we already own: vaccines, tobacco control, weight, alcohol, sun and infection control.
- Overdiagnosis and false alarms · Finding more cancer is not the same as saving lives. Screening also finds cancers that would never have hurt anyone, and treats them.
Pages like this
not linked directly; found by shared links- Key paperNHS-Galleri: design of the largest randomised trial of a multi-cancer blood test
Shares PATHFINDER 2, NHS-Galleri, Galleri, Positive predictive value (PPV).
- Key paperPATHFINDER: the first prospective test of a multi-cancer blood test in people without symptoms
Shares PATHFINDER 2, NHS-Galleri, Galleri, Positive predictive value (PPV).
- IdeaLet MCED trials read out on late-stage incidence, with mortality follow-up mandated
Shares PATHFINDER 2, NHS-Galleri, Galleri, Stage shift.
- RoadmapEarly detection roadmap: organ screening → blood tests for many cancers
Shares PATHFINDER 2, NHS-Galleri, Whole-body MRI, Galleri.
- IdeaA 28-day national pathway for people with a positive multi-cancer blood test
Shares FAPI PET as the workup for MCED positives, Whole-body MRI, Positive predictive value (PPV), Multi-cancer early detection (MCED).
- IdeaMulti-cancer blood test as the first step for patients with non-specific symptoms
Shares Galleri, Positive predictive value (PPV), Multi-cancer early detection (MCED), Most lethal cancers are found late.
- IdeaPre-agreed update rules so an MCED test is not obsolete when its trial reads out
Shares PATHFINDER 2, NHS-Galleri, Multi-cancer early detection (MCED), Most lethal cancers are found late.
- Key paperDETECT-A: a blood test plus PET-CT found treatable cancers in 10,000 women with no symptoms
Shares Positive predictive value (PPV), Stage shift, Multi-cancer early detection (MCED), Overdiagnosis and false alarms.